Dr. Abdullah Abou-Samra, MD

Dr. Abou-Samra practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Abou-Samra's NPI, 1134757479, was assigned on March 31, 2020. Dr. Abou-Samra graduated from University of South Florida College of Medicine in 2020. Dr. Abou-Samra holds Virginia license 0101281391.

Dr. Abou-Samra's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Abou-Samra's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Abou-Samra is also affiliated with MedStar Washington Hospital Center. Dmand AI also links Dr. Abou-Samra to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abou-Samra practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Abou-Samra's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Abou-Samra's licenses on file in 3 states: Virginia, District of Columbia and Maryland.

CMS data shows 160 Medicare services from Dr. Abou-Samra across 6 procedure codes in 2024, for 120 Medicare patients. Medicare paid $12,637 for them.

CMS counts 120 Medicare patients who saw Dr. Abou-Samra in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abou-Samra's median patient age at 62, with 45% women.

In 2024, Dr. Abou-Samra wrote 181 Medicare Part D claims for 63 patients. 69% of them were for generic drugs. CMS names the drug for 134 of them, across 6 drugs with 11 or more claims each, at $3,231 in total drug cost. In 2023, CMS named 243 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Abou-Samra for performance year 2024, reported as part of a group. Dr. Abou-Samra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Abou-Samra, published from 2018 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging. Dr. Abou-Samra has published most often in Ocul Immunol Inflamm. Dr. Abou-Samra's most frequent co-authors are Yevgeniy Shildkrot, MD, Mohammed Kairy Barazi, MD and Enrico Mario Camporesi, MD.

CMS Open Payments shows 29 general payments to Dr. Abou-Samra from 11 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,058.

Dr. Abou-Samra graduated from University of South Florida College of Medicine in 2020.